S7 Ep15: Monk Recaps Benefit of Rucaparib Maintenance Therapy in Advanced Ovarian Cancer
Jul 18, 2022
08:03
forum Ask episode
view_agenda Chapters
auto_awesome Transcript
info_circle Episode notes
Dr Monk discusses pertinent efficacy and safety data from the ATHENA-MONO trial, which evaluated first-line maintenance treatment with rucaparib in patients with stage III-IV high-grade ovarian cancer.
OncLive® On Air